HIV-1 treatment as prevention: the good, the bad, and the ch... : Current Opinion in HIV and
AIDS HIV-1 treatment as prevention: the good, the bad, and the challenges : Current Opinion in …

There are four opportunities for HIV prevention: before exposure, at the moment of exposure,
immediately after exposure, and as secondary prevention focused on infected subjects. Until …

Antiretroviral therapy (ART), for those who have access, has revolutionised the morbidity
and mortality consequences of HIV infection. By the end of 2010, 6.6 million people living …

1. BAckground In 2010, an estimated 34 million people were living with the human
immunodeficiency virus (HIV), around 70% of them in sub-Saharan Africa. By the end of …

Until now, decisions about how to allocate ART have largely been based on maximising the
therapeutic benefit of ART for patients. Since the results of the HPTN 052 study showed …

There is considerable scientific evidence supporting the use of antiretroviral therapy (ART)
in prevention of human immunodeficiency virus (HIV) and tuberculosis (TB) infections. The …

In the past several years, the debate of “treatment vs prevention” has shifted with the
introduction of the concept of “treatment as prevention,”(TasP), stemming from a series of …

This review considers the use of antiretroviral drugs specifically to prevent HIV transmission.
Antiretroviral therapy (ART) can be implemented for the protection of uninfected individuals …

The use of antiretroviral therapy (ART) has been associated with significant improvement in
morbidity and survival of persons living with HIV. In addition, recently, there has also been …

Earlier ART may confer clinical benefits, and ART regimens are becoming safer and better-
tolerated. However, high-quality data are urgently needed with regards to the acceptability …